The opiate antagonist, naloxone, which is associated with prolonged survival in animal models of shock, has been demonstrated to increase arterial pressure and cardiac output. It is possible that the increase in cardiac output is due to a decrease in volume in the total capacitance vasculature and a subsequent increase in venous return. Because the influence of naloxone on the capacitance vasculature is unknown, the present study was undertaken to determine the influence of naloxone on intravascular volume in the total capacitance circulation. Other investigators have observed prolonged survival with naloxone administration in various hypotensive experimental conditions including endotoxin shock (1) and hypovolemic shock (2-4). The prolonged survival may be related to increases in cardiac contractility, cardiac output, and mean arterial pressure, which have been observed after administration in hypotensive animals (1-9) or patients (10, 11). It is also possible that the increases in cardiac output and arterial pressure are due, in part, to a decrease in capacitance volume; however, capacitance volume changes have not been previously examined.
Introduction
The opiate antagonist, naloxone, which is associated with prolonged survival in animal models of shock, has been demonstrated to increase arterial pressure and cardiac output. It is possible that the increase in cardiac output is due to a decrease in volume in the total capacitance vasculature and a subsequent increase in venous return. Because the influence of naloxone on the capacitance vasculature is unknown, the present study was undertaken to determine the influence of naloxone on intravascular volume in the total capacitance circulation. In 31 anesthetized dogs, blood from the vena cavae was drained into an extrmcorporeal reservoir and returned to the right atrium at a constant rate so that changes in total intravascular volume could be measured as reciprocal changes in reservoir volume. In five animals, naloxone infusion (2 mg/ml. min for 20 min) was associated with a decrease in total capacitance volume of 121±30 ml (P < 0.05). To determine regional volume effects, naloxone was infused in 11 animals in which the splanchnic and extrasplanchnic vasculatures were separately perfused and drained: total and splanchnic volume decreased 64±13 ml (P < 0.05) and 126±17 ml (P < 0.0001), respectively, and extrasplanchnic volume increased 62±13 ml (P < 0.001). After ganglionic blockade with mecamylamine (n = 3), total volume decreased 89±16 ml (P < 0.05), splanchnic volume did not change, and extrasplanchnic volume decreased 91±32 ml (P < 0.05). In another five animals, naloxone was infused during diversion of the splanchnic venous outflow to a nonrecirculating extracorporeal reservoir: total volume decreased 122±33 ml Naloxone, an opiate antagonist, has been demonstrated to improve cardiovascular performance and prolong survival in hypotensive animals. It is possible that the improved cardiovascular performance is related, in part, to a decrease in intravascular volume in the total capacitance vasculature and a subsequent increase in venous return. Because the influence of naloxone on the capacitance vasculature has not been examined, the present study was undertaken to examine whether volume in the total capacitance Vasculature is decreased during naloxone administration.
Other investigators have observed prolonged survival with naloxone administration in various hypotensive experimental conditions including endotoxin shock (1) and hypovolemic shock (2) (3) (4) . The prolonged survival may be related to increases in cardiac contractility, cardiac output, and mean arterial pressure, which have been observed after administration in hypotensive animals (1) (2) (3) (4) (5) (6) (7) (8) (9) or patients (10, 11) . It is also possible that the increases in cardiac output and arterial pressure are due, in part, to a decrease in capacitance volume; however, capacitance volume changes have not been previously examined.
Hence, the present study was undertaken in order to assess the influence of naloxone administration on the total capacitance vasculature. A venous bypass preparation was employed to determine regional and total intravascular volume changes and the extent to which these changes are mediated by direct, neurogenic, and hormonal influences.
Methods
Venous bypass preparation. 31 mongrel dogs of either sex, weighing between 11 and 18 kg (mean 14±0 kg) were anesthetized with chloralose (60-80 mg/kg iv) and urethan (600-800 mg/kg iv), intubated, and ventilated with a mixture of room air and 100% oxygen. A median sternotomy was performed and 3,000 U of sodium heparin was administered iv. The experimental preparation utilized in dogs 1-10 is illustrated in Fig. 1 . The azygos vein was ligated and the superior and inferior vena cavae were cannulated with no. 32 or 34 French catheters. The total systemic venous return was drained to an overflow column and central venous pressure was adjusted by setting the height of the column at 5 cm H20 with the right atrium as a reference point. The Figure 1 . Experimental preparation employed. Animals were placed on venous bypass and changes in total Splanchnic evisceration preparation. In dogs 3-10, the influence of naloxone administration on the isolated extrasplanchnic vasculature was assessed by infusing naloxone again into the left atrium at a rate of 2 mg/ml * min after evisceration of the splanchnic vasculature. The preparation illustrated in Fig. 1 Fig. 2 . In 21 animals (dogs 11-31), the celiac, cranial mesenteric, and caudal mesenteric arteries were isolated and separately perfused by a perfusion pump with blood drained from a femoral artery. Splanchnic perfusion was at a constant rate of 180-300 ml/ min (mean 226±9 ml/min) and extrasplanchnic perfusion at a constant rate of 400-700 ml/min (mean 537±32 ml/min). An into the left atrium for 20 min without diversion and again during diversion of the splanchnic venous outflow in dogs 22-26. In dog 27, naloxone was first infused during splanchnic venous diversion.
In dogs 24-27, the influence of the diverted splanchnic venous effluent on extrasplanchnic volume was examined directly by reinfusing the splanchnic venous effluent after splanchnic evisceration had been accomplished. The splanchnic vasculature was eviscerated in each of these four animals as described previously. After a 10-20-min precontrol period was obtained, blood that had been stored in the nonrecirculating splanchnic venous reservoir during the previous naloxone infusion was added to the 2-liter graduated cylinder over a 20-min period without concurrent naloxone administration. Changes in extrasplanchnic vascular volume were determined as in the previous set of experiments.
In dogs 28-31, naloxone was first administered during splanchnic venous diversion and the diverted splanchnic outflow was then reinfused over a 20-min period without concurrent naloxone administration and without prior abdominal evisceration. Changes in total, splanchnic, and extrasplanchnic volumes were examined by measuring changes in splanchnic and extrasplanchnic venous outflow as described previously.
Whether the diversion and reinfusion technique alone influenced the present observations was examined in dogs 28 and 29. At the beginning of each study, total and regional volume changes were examined during 20 min of diversion without naloxone administration and then during 20 min of reinfusion of the previously diverted splanchnic venous outflow.
To determine whether shifts in fluid volume between the intravascular and extravascular spaces may have influenced the observed volume changes, hematocrits were determined on four occasions before and after naloxone administration.
Brief naloxone infusions. Whether the total and regional volume responses associated with naloxone administration could be observed to return to precontrol levels during the postcontrol period, after a shorter duration of naloxone administration, was examined in dogs 30 and 31. In each of these two animals, splanchnic and extrasplanchnic venous outflows were measured and total, splanchnic, and extrasplanchnic volume changes were calculated during naloxone administration (2 mg/ml -min) for 14 
Results
The mean data associated with seven periods of naloxone infusion in five animals, without the prior administration of exogenous opiates, are presented in Fig. 3 nic volume decreased 88±14 ml (P < 0.05) and extrasplanchnic volume increased 47±8 ml (P < 0.05).
Naloxone was associated with decreases in total intravascular volume both before and after splanchnic evisceration. Intravascular volume decreased 69±13 ml (P < 0.01) before splanchnic evisceration and 85±23 ml (P < 0. Fig. 4 . Naloxone infusion was associated with decreases in both total and splanchnic intravascular volume of 64±13 ml (P < 0.05) and 126±17 ml (P < 0.0001), respectively, and with an increase in extrasplanchnic volume of 62±13 ml (P < 0.001) during 14 liter/min (P < 0.001). Mean systemic arterial pressure increased from 63±3 to 71±4 mmHg (P < 0.01) while portal pressure (increase from 15±1 to 16±1 cmH2O) and hepatic resistance (decrease from 59±16 to 58±7 cmH2O min/liter) did not change significantly.
In two animals in which naloxone was administered for only 14 min and in which a longer postcontrol period was observed, regional and total volumes had begun to return towards precontrol levels by 6-14 min after termination of infusion and had returned completely to precontrol levels by the end of the postcontrol period.
Repetitive infusion of naloxone was not associated with a significant attenuation of the total or regional volume responses. In four animals in which morphine had not been previously administered, repetitive naloxone infusion on five occasions was associated with decreases in total intravascular volume of 99±41 (NS) and 74±23 ml (P < 0.05), respectively. These changes were not significantly different from each other. In the two of these animals with separate perfusion and drainage, repetitive drug administration on three occasions was associated with decreases in splanchnic volume of 92±40 (NS) and 75±16 ml (P < 0.05) and with increases in extrasplanchnic volume of 47±29 (NS) and 35±24 ml (NS). These changes did not differ significantly.
The data associated with naloxone infusion before and after ganglionic blockade in three animals with separate perfusion and drainage of the splanchnic and extrasplanchnic vasculatures are presented in Fig. 5 . Naloxone infusion was associated with a total intravascular volume decrement of 104±34 ml (NS) before ganglionic blockade which did not differ significantly from the 89±16 ml (P < 0.05) decrement after blockade. The splanchnic intravascular volume decrement of 171±31 ml (P < 0.05) before ganglionic blockade was abolished after blockade. These responses were significantly different from each other (P < 0.05). The extrasplanchnic volume increment of 67±9 ml (P < 0.0001) during naloxone infusion before ganglionic blockade was significantly different (P < 0.05) from the volume decrement of 91±32 ml (P < 0.05) after blockade. Mean systemic arterial pressure increased from 64±7 to 77±1 mmHg (NS) before blockade and decreased from 104±12 to 89±5 mmHg (NS) after blockade. Hepatic resistance and portal pressure did not change significantly before or after blockade.
In Fig. 6 Fig. 7 . The total volume decrement of 71±10 ml (P < 0.05) during naloxone infusion with splanchnic diversion did not differ significantly from the total volume decrement of 43±5 ml (P < 0.05) during reinfusion of the splanchnic outflow. The absence of a significant splanchnic volume change during naloxone with diversion was significantly different (P < 0.01) from the splanchnic volume decrement of 113±14 ml (P < 0.05) during splanchnic venous reinfusion. The extra- (F7,12 = 10.23, P < 0.0001). Middle, the insignificant splanchnic volume change with diversion (F7,12 = 1.13, NS) differed significantly (P < 0.01) from the decrement during reinfusion (F., 2 = 11.12, P < 0.001). Bo~ttom, the extrasplanchnic volume decrement with naloxone during diversion (F,1 2 = 10.96, P < 0.001) diffiered significantly (P < 0.01) from the volume incremept during reinfusion (F7,12 = 10.26, P < 0.01). Each bar~represents ±1 SEM. *, P < 0.05; +, P < 0.01; (.), naloxone infusion with splanchnis fliversion (n = 4); (o), splanchnic venous effluent reinfusion (n = 4).
rement of 93±16 ml (P < 0.05) during naloxone infusion with splanchnic diversion was significantly different (P < 0.001) from the extrasplanchnic volume increment of 71±7 ml (P <0.01) during reinfusion without naloxone administration. Mean systemic arterial pressure did not change significantly with splanchnic effluent reinfusion (increase from 64±6 to 70±9 mmHg).
In two animals, diversion of the splanchnic venous outflow, without concurrent naloxone administration, and subsequent reinfusion of the previously diverted outflow were associated with total, splanchnic, and extrasplanchnic volume changes of <9 ml.
In the four animals in which the influence of mecamylamine was examined, mean arterial pressure decreased from 66±8 to 47±4 mmHg (P < 0.05) by 7±2 minutes (range 2-10 min) after mecamylamine administration. At the time of this maximal effect on arterial pressure, total intravascular volume had increased 22±23 ml (NS). It would appear that the total intravascular volume change had stabilized by this time, in that the volume change 5 Table I .
Discussion
The present data demonstrate that naloxone administration is associated with a decrease in intravascular volume in the total capacitance vasculature. The total volume decrement is due to a decrease in splanchnic intravascular volume and occurs despite an increase in extrasplanchnic volume. The data also suggest the mechanisms responsible for the total and regional volume responses. though the increment occurs despite a direct influence of naloxone to decrease extrasplanchnic volume. A naloxoneinitiated autonomic reflex is necessary for the volume increment to occur, because the extrasplanchnic volume increment was abolished after ganglionic blockade. It would appear that a vasoactive hormone is subsequently released from the splanchnic vasculature and acts to increase extrasplanchnic volume, because the extrasplanchnic volume increment was abolished by diversion of the splanchnic venous effluent or by abdominal evisceration and was reestablished by reinfusion of the previously diverted splanchnic outflow in both the intact and eviscerated animals. Naloxone is also associated with a direct effect that acts to decrease extrasplanchnic volume, because naloxone administration was associated with decreases in extrasplanchnic volume after ganglionic blockade, splanchnic venous diversion, or abdominal evisceration. Because mecamylamine administration is known to have significant effects on the circulation, one might argue that the volume changes associated with naloxone administration after ganglionic blockade were due to the effects of mecamylamine alone. However, this interpretation is unlikely for the following reasons. First, the maximal arterial pressure and intravascular volume effects appeared within 10 min of mecamylamine administration, whereas naloxone administration did not begin until at least 50 min after mecamylamine administration.
Second, 20 min of hemodynamic stability was documented before the onset of all naloxone infusions after mecamylamine administration. Finally, the total volume response associated with mecamylamine alone was directionally different from the response associated with naloxone administration after ganglionic blockade. (19) . However, hepatic resistance and portal pressure did not change although splanchnic volume decreased during naloxone administration. Hence, the identity of the hormonal substance is not suggested by data obtained from either the present study or other studies. It is possible that the substance is a vasoactive peptide released from the gastrointestinal wall.
In addition to the neurogenic and hormonal influences of naloxone on the splanchnic and extrasplanchnic vasculatures, naloxone administration has a direct effect on the extrasplanchnic vasculature. Prior work has demonstrated the presence of opiate receptors in multiple sites in the central nervous system (20) and in such peripheral tissues as guinea pig ileum, mouse vas deferens, and rat vas deferens (20) (21) (22) . Furthermore, Curtis and Lefer (5) have demonstrated a modest positive inotropic effect of high concentrations of naloxone in cat papillary muscle. In addition to the demonstration of opiate receptors at multiple sites, at least five distinct opiate receptor types, which differ in their affinity for various agonists and antagonists, have been identified in the central nervous system and in peripheral tissues (22) . The existence of naloxonesensitive receptors in vascular smooth muscle has not been documented previously. The present study suggests the existence of such opiate receptors in the extrasplanchnic capacitance vasculature of the dog.
The observation that total and regional intravascular volume changes did not return towards precontrol levels after termination of the infusion may have been related to both the cumulative amount of naloxone administered for 20 min and to the relatively short postcontrol period. This hypothesis is supported by our observation that total, splanchnic, and extrasplanchnic volume changes returned to precontrol levels in the two animals in which naloxone was infused for only 14 min and in which hemodynamic monitoring was continued for a longer postcontrol period.
The presently observed base-line mean arterial pressure of 60 mmHg is comparable to the base-line values observed by other investigators who have examined the influence of naloxone on survival in hypotensive animals not on bypass (1) (2) (3) (4) 9) . However, even though the present base-line pressure is comparable to that in hypotensive animals not on bypass, the present total and regional intravascular volume responses are not dependent upon this lower pressure, because the total and regional volume changes are similar in animals with higher and lower base-line arterial pressures.
It might have been expected that prior administration of an exogenous opiate would be necessary to demonstrate a naloxone-associated total intravascular volume change. However, the present data demonstrate that such administration is not necessary either at lower or higher base-line arterial pressures. Furthermore, the regional volume changes and the neurogenic and hormonal influences that apparently mediate these changes are not dependent upon prior opiate administration. A possible explanation for this observation is that the surgery required for the bypass preparation was extensive enough to cause release of endogenous opiates and subsequent naloxone administration reversed the effects of these opiates. Such an explanation is consistent with the work of Dashwood and Feldberg (23) in that they observed arterial pressure increments associated with naloxone administration alone, after extensive surgery. While Dashwood and Feldberg suggest that the arterial pressure response is dependent upon the release of adrenal hormones, our data would suggest that the intravascular volume response is dependent upon the release of a splanchnic hormone.
The mean arterial pressure increase observed in the present study is less than that reported by other investigators (1) (2) (3) (4) , who infused naloxone at similar rates (0.5-2.0 mg/min). This difference may be due to the fact that blood was returned to the right atrium at a constant rate in the present study. If naloxone administration is associated with an increase in venous return in an intact animal, this increase would be expected to contribute to a greater elevation in arterial pressure than was observed in the present study.
In an animal not on bypass, it would be expected that the naloxone-mediated capacitance volume decrement would be associated with increases in venous return, ventricular enddiastolic pressure, and cardiac output. Because intravascular volume decreases 121 ml (8.6 ml/kg) in the present study in an animal on bypass without the prior administration of exogenous opiates, it would be expected that mean circulatory filling pressure would increase 4.3 mmHg in a hypotensive animal not on bypass (estimated vascular compliance 2.0 ml/ mmHg'kg [24]1). From the work of Guyton and colleagues (25, 26) , it would be expected that such an increase in mean circulatory filling pressure would be associated with an increase in cardiac output of as much as 60% in an intact dog, although sinoaortic baroreceptor reflexes and changes in cardiac afterload might modify this effect.
In summary, the present study demonstrates that naloxone administration is associated with a decrease in splanchnic intravascular volume and an increase in extrasplanchnic intravascular volume. The data suggest that the splanchnic volume decrement and extrasplanchnic volume increment are dependent upon the neurogenic release of an unidentified splanchnic hormone. The extrasplanchnic volume increment occurs despite the tendency of naloxone to decrease extrasplanchnic volume through a direct effect on the extrasplanchnic vasculature. Regardless of the mechanisms responsible for the regional volume changes, it is apparent that naloxone administration is associated with a decrease in total intravascular volume and this decrease is due to the decrease in splanchnic volume. Hence, the beneficial effect of naloxone in the experimental treatment of patients with acute hypotension may be due, in part, to mobilization of peripheral blood volume, an increase in venous return, and subsequent enhancement of cardiac output.
